• 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

301130 Share Price Performance

CN¥31.75
5.02 (18.78%)
CN¥31.75
5.02 (18.78%)
Price CN¥31.75

301130 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet unattractive dividend payer.

2 Risks
0 Rewards

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Key Details

CN¥252.8m

Revenue

CN¥60.0m

Cost of Revenue

CN¥192.8m

Gross Profit

CN¥153.4m

Other Expenses

CN¥39.3m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 29, 2026
0.51
76.26%
15.57%
1.1%
View Full Analysis

About 301130

Founded
1990
Employees
320
CEO
Jun Zhang
WebsiteView website
xidianyy.com

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd engages in the research and development, production, and sales of chemical raw materials and pharmaceutical preparations in China. The company provides drugs for the treatment of anemia, mental disorders, anti-psychotic disorders, cardiovascular and cerebrovascular diseases, and tumors. It provides drugs in the form of tablets and capsules. The company was founded in 1990 and is headquartered in Panshi, China.

Recent 301130 News & Updates

Recent updates

No updates